Advocacy intelligence hub — real-time data for patient organizations
UNICANCER — PHASE2
UNICANCER — PHASE2
University of Chicago — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Dihydropyrimidine dehydrogenase deficiency news →
Marie-Anne LORIOT
Hopital Europeen Georges Pompidou
Valérie BOIGE, MD
Gustave Roussy Cancer Campus
Emmanuelle SAMALIN, MD
Institut du Cancer de Montepllier
Oleg A Shchelochkov, M.D., MD
National Human Genome Research Institute (NHGRI)
📍 IOWA CITY, IA
Peter H. O'Donnell, MD, psychologist
University of Chicago
📍 ALTOONA, PA
Jean Marc Ferrero, MD
Centre Antoine Lacassagne
View all Dihydropyrimidine dehydrogenase deficiency specialists →